noting appreciation work done technology economic assessment panel medical technical options committee mindful that according decision iv use chlorofluorocarbons metered inhalers qualify essential use technically economically feasible alternatives substitutes available acceptable standpoint environment health noting technology economic assessment panel conclusion technically satisfactory alternatives chlorofluorocarbon metered dose inhalers available short beta agonists therapeutic categories asthma chronic obstructive pulmonary disease mindful paragraph decision xii allows transfer chlorofluorocarbons metered dose inhaler companies welcoming continued progress several parties operating paragraph article reducing reliance on chlorofluorocarbon based metered dose inhalers alternatives developed receive regulatory approval marketed sale authorize levels production consumption necessary satisfy essential uses chlorofluorocarbons metered dose inhalers asthma chronic obstructive pulmonary disease specified annex present decision parties operating paragraph article montreal protocol licensing authorizing allocating essential use exemptions manufacturer metered inhalers shall ensure accordance paragraph decision iv pre post stocks controlled substances taken account one year operational supply maintained manufacturer annex decision xx essential use authorizations chlorofluorocarbons metered dose inhalers approved twentieth meeting parties party quantity metric tonnes european community united states america russian federation